Publications 

Empowering High Throughput Screening of 3D Models: Automated Dispensing of Cervical and Endometrial Cancer Cells

Seymour S, Cadena I, Johnson M, Jenne M, Adem I, Frankovic R, Spence D, Haddadin A, Fogg KC

bioRxiv. 2024 March 9. https://doi.org/10.1101/2024.03.06.583783

Development of a 3D in vitro human-sized model of cervical dysplasia to evaluate the delivery of ethyl cellulose-ethanol injection for the treatment of cervical dysplasia ablation

Cadena IA, Adhikari G, Almer A, Jenne M, Obasi N, Zurita NF, Rochefort WE, Mueller JL, Fogg KC

bioRxiv. 2024 February 23. https://doi.org/10.1101/2024.02.20.581242

Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods

Cadena IA, Rowlands C, Buchanan MR, Jenne MA, Keefe B, Almer A, Obasi N, Harris CG, Rochefort WE, Givens BE, Fogg KC. 

bioRxiv. 2024 February 23. https://doi.org/10.1101/2024.02.20.581239

Empowering high-throughput high-content analysis of 3D tumor models: Open-source software for automated non-confocal image analysis

Wiggin N, Cook C, Black M, Cadena I, Rahal-Arabi S, Fogg KC.

bioRxiv. 2024 February 23. https://www.biorxiv.org/content/10.1101/2024.02.20.581231v1

Characterizing the Extracellular Matrix Transcriptome of Endometriosis

Cook CJ,  Wiggin N, Fogg KC.  

Reprod Sci. 2024 Feb;31(2):413-429.  doi: 10.1007/s43032-023-01359-w. 

Engineering High Throughput Screening Platforms of Cervical Cancer

Cadena IC, Buchanan MR, Harris CG, Jenne MA, Rochefort WE, Nelson D, Fogg KC.  

JMBR Part A. 2023 Mar 2.  doi: 10.1002/jbm.a.37522.  

Roadmap on Biomaterials for Women’s Health. 

Fogg KC, Tseng N-H, Peyton SR, Holeman P, McLoughlin ST, Fisher JP, Sutton A, Shikanov A, Gnecco JS, Knight KM, Slaby E, Weaver JD, Hashemi N, Zhang Y, House MD, Vogt BJ, Aguado BA, Bradford J, Robinson JL, Thomas PK, Lau AG, Oyen ML. 

J Phys Mater. J. Phys. Mater. 6 012501. doi: 10.1088/2515-7639/ac90ee.

Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers. 

Cook CJ, Miller AE, Barker T, Di Y, Fogg KC

Matrix Biol. Plus. 2022 Aug 8. doi:10.1016/j.mbplus.2022.100117.

Quantitative Analysis of the Extracellular Matrix by Immunoblot.

Fogg KC.

Methods Mol Biol. 2021 Dec 17. doi: 10.1007/978-1-0716-1956-8_7.

Biomaterial strategies to replicate gynecological tissue. 

Cadena IC, Chen A, Arvidson A, Fogg KC.

Biomater Sci. 2020 Nov 24. doi: 10.1039/d0bm01240h. 

Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway.

Fogg KC, Miller AE, Li Y, Flanigan W, Walker W, O’Shea A, Kendziorski C, Wellik D, Weisman PS, Kreeger PK. 

BMC Cancer. 2020 Oct 17. doi: 10.1186/s12885-020-07513-w.

Ovarian cancer cells have increased proliferation in response to HB-EGF as collagen density increases

Fogg KC, Renner C, Christian H, Walker A, Marty-Santos L, Khan A, Olson W, Parent C, O’Shea A, Wellik D, Weisman PS, Kreeger PK. 

Tissue Eng Part A. 2020 Jun 25. doi: 10.1089/ten.tea.2020.0001. 

Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway. 

Fogg KC, Olson WR, Miller JN, Khan A, Renner C, Hale I, Weisman PS, Kreeger PK. 

Cancer Lett. 2019 Aug 28. doi: 10.1016/j.canlet.2019.05.029. 

Alternatively-activated macrophages upregulate mesothelial expression of P-selectin to enhance adhesion of ovarian cancer cells. 

Carroll MJ, Fogg KC, Patel HA, Krause HB, Mancha AS, Patankar MS, Weisman PS, Barroilhet L, Kreeger PK. 

Cancer Res. 2018 Jul 1. doi: 10.1158/0008-5472.CAN-17-3341.